Clinical Trial Update: Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer [Phase 2, Phase 3]

View source ↗

Summary

This is a Phase 2/3 clinical trial update evaluating recombinant endostatin with neoadjuvant chemotherapy followed by concurrent chemoradiation for advanced nas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Endostatin (endostatin)

Snippet

Sponsor: Jin Feng | Conditions: 1、Enough Cases, 2、Elekta Precise 1343 Digital Control Electron Linear Accelerator | Phase 2, Phase 3 | Status: UNKNOWN